Catabasis Pharmaceuticals, Inc. Gains 70.78%

Fri 29 Jan 21 at 05:30 PM
Catabasis Pharmaceuticals, Inc. Gains 70.78%

Catabasis Pharmaceuticals, Inc. (CATB:NASDAQ) shot up at $4.15, representing a gain of 70.8%. On Thu 28 Jan 21, CATB:NASDAQ touched a New 2-Week Low of $2.43. The stock got featured on our News Catalysts scanner on Fri 29 Jan 21 at 10:08 AM in the 'ACQUISITION' category. From Thu 14 Jan 21, the stock recorded 33.33% Up Days and 40.00% Green Days

The stock spiked on Wed 02 Dec 20 at $3.25 with a volume of 198M+, and its share price has been moving sideways in recent weeks.

About Catabasis Pharmaceuticals, Inc. (CATB:NASDAQ)

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's primary focus is on treatments for rare diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.